To the best of our knowledge, FGF6 signalling has not been associated with any phenotype in breast cancer neither in vitro nor in vivo, whereas FGF4 and FGF5 seem to have overlapping but also specific roles. The gene discussed is FGF5; the disease is breast cancer.